first large study of glp-1 receptor agonists during pregnancy PDF) Agonist Use in New developments in GLP-1 agonist
Description
Effects in PCOS GLP-1 RAs have been extensively studied in women with PCOS due to overlapping metabolic abnormalities
LEADER Trial Investigators
In the US, Wegovy is approved for use in individuals with a BMI over 30 with no other co-morbidities and 27 in individuals with a weight-related condition, such as hypertension
Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function
TBR News Media
Reliance on any information provided in this article is solely at your own risk
